A carregar...
Downregulation of GPSM2 is associated with primary resistance to paclitaxel in breast cancer
Paclitaxel is one of the most effective chemotherapy drugs for breast cancer worldwide but 20–30% patients show primary resistance to the drug. Screening and identification of markers that facilitate effective and rapid prediction of sensitivity to paclitaxel is therefore an urgent medical requireme...
Na minha lista:
| Publicado no: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7041173/ https://ncbi.nlm.nih.gov/pubmed/32020211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2020.7471 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|